Cargando…
Potential lipid-based strategies of amphotericin B designed for oral administration in clinical application
Amphotericin B (AmB) is regarded as a first-line therapy against life-threatening invasive fungal infections. Due to its poor oral bioavailability, AmB is restricted to intravenous administration in clinical practice. As science continues to move forward, two lipid-based formulations are successfull...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828648/ https://www.ncbi.nlm.nih.gov/pubmed/36601799 http://dx.doi.org/10.1080/10717544.2022.2161671 |